Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

262 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.
Baselga J, Swain SM. Baselga J, et al. Nat Rev Cancer. 2009 Jul;9(7):463-75. doi: 10.1038/nrc2656. Epub 2009 Jun 18. Nat Rev Cancer. 2009. PMID: 19536107 Review.
Pertuzumab for the treatment of breast cancer.
Lynce F, Swain SM. Lynce F, et al. Cancer Invest. 2014 Oct;32(8):430-8. doi: 10.3109/07357907.2014.922570. Epub 2014 Jun 12. Cancer Invest. 2014. PMID: 24921704 Review.
Circulating biomarkers of bevacizumab activity in patients with breast cancer.
Denduluri N, Yang SX, Berman AW, Nguyen D, Liewehr DJ, Steinberg SM, Swain SM. Denduluri N, et al. Cancer Biol Ther. 2008 Jan;7(1):15-20. doi: 10.4161/cbt.7.1.5337. Epub 2007 Nov 21. Cancer Biol Ther. 2008. PMID: 18059178
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel.
Cortés J, Swain SM, Kudaba I, Hauschild M, Patel T, Grincuka E, Masuda N, McNally V, Ross G, Brewster M, Marier JF, Trinh MM, Garg A, Nijem I, Visich J, Lum BL, Baselga J. Cortés J, et al. Anticancer Drugs. 2013 Nov;24(10):1084-92. doi: 10.1097/CAD.0000000000000016. Anticancer Drugs. 2013. PMID: 23969513 Clinical Trial.
Primary systemic chemotherapy for inflammatory breast cancer.
Sinclair S, Swain SM. Sinclair S, et al. Cancer. 2010 Jun 1;116(11 Suppl):2821-8. doi: 10.1002/cncr.25166. Cancer. 2010. PMID: 20503414 Review.
Pertuzumab for the treatment of breast cancer: a safety review.
Gao J, Swain SM. Gao J, et al. Expert Opin Drug Saf. 2016 Jun;15(6):853-63. doi: 10.1517/14740338.2016.1167185. Epub 2016 Apr 12. Expert Opin Drug Saf. 2016. PMID: 26982349 Review.
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer.
Baselga J, Cortés J, Im SA, Clark E, Ross G, Kiermaier A, Swain SM. Baselga J, et al. J Clin Oncol. 2014 Nov 20;32(33):3753-61. doi: 10.1200/JCO.2013.54.5384. Epub 2014 Oct 20. J Clin Oncol. 2014. PMID: 25332247 Clinical Trial.
262 results
Jump to page
Feedback